Differentiate common and uncommon nerve disorders
Understand red flag symptoms
Discuss management options in the ED
OBJECTIVES
35 y/o F w/ BLE numbness
Started in feet, ascended to calves and now thighs
Today had difficulty emptying bladder
CASE 1
Abd: slightly ttp lower abd w/o rebound or guarding, + lower
abd fullness
Neuro: 3/5 strength LLE, 5/5 strength RLE
Normal vibration/proprioception
Decreased pain and temp T10 and below
Deep tendon reflexes (DTRs) absent BLE
R foot drop
CASE 1
Foley: 1 L output
DDx?
Guillain-Barre syndrome
Multiple sclerosis
Spinal neoplasm vs. hematoma
Transverse myelitis
CASE 1
Interruption of ascending and descending pathways in the
transverse plane of spinal cord
Autoimmune response or direct infection
Ages 10-19, 30-39
TRANSVERSE MYELITIS
Motor weakness, sensory abnormalities, bowel/bladder
dysfunction
Usually bilateral
Pain and temp lost below well-defined level (distinguishes
from peripheral lesions)
MRI
High-dose steroids (anecdotal), plasma exchange (best)
TRANSVERSE MYELITIS
39 y/o M pmh HCV, heroin abuse
Bilateral upper and lower weakness, neck pain
Difficulty with urination
CASE 2
Vitals normal
HEENT, Pulm, Cards, Abd normal
Neuro: BUE 3/5 strength, normal DTRs
BLE 2/5 strength, absent DTRs
C6 tender to palpation
CASE 2
60 y/o M w/ numbness and paresthesias of bilateral legs x 1
month
Difficulty walking x 1 year
New erectile dysfunction and occasional urinary incontinence
Progressively blurry vision
Multiple sexual partners
Painless genital lesions 10 years ago
CASE 3
Pupils constrict on accommodation, no response to light
BUE normal strength/DTRs; BLE exam normal strength, absent
DTRs
Joint position and vibration impaired below ASIS
Ataxic gait; loss of balance when standing w/ eyes closed
CASE 3
Late manifestation of neurosyphilis
Slow progressive degeneration of posterior columns
Proprioceptive, vibratory and fine touch input
TABES DORSALIS
Acute inflammatory demyelinating polyneuropathy
Progressive, symmetric distal weakness
Days to weeks after URI or GI illness
Usually worse in LE, partial or complete loss of DTRs, variable
sensory findings
GUILLAIN-BARRE SYNDROME
MCC: C. jejuni, CMV, EBV, M. pneumoniae
High concern for respiratory compromise
Dx: LP (CSF w/ markedly elevated protein w/ normal WBC)
GUILLAIN-BARRE SYNDROME
Always check FVC and negative inspiratory force
• FVC < 20 ml/kg or NIF < 30 cm H2O impending respiratory
compromise: intubate
• If ABG shows alveolar hypoventilation (elevated pCO2) intubate
GUILLAIN-BARRE SYNDROME
Treatment: IVIG, plasma exchange
No proven benefit to steroids
GUILLAIN-BARRE SYNDROME
42 y/o M w/ HA, dizziness, myalgias, malaise x 2 days
Worsening weakness in BLE and now has gait instability
Hiking in Colorado 5 days prior
CASE 5
BUE 5/5 strength, normal DTRs, sensory intact
BLE 3/5 strength, absent DTRs, sensory intact
L medial thigh
CASE 5
Rocky Mountain states, Pacific Northwest
6 main species, including Ixodes and Dermacentor
Neurotoxin inhibits presynaptic ACh release at NMJ
TICK PARALYSIS
Death from respiratory muscle paralysis
Treatment: removal of tick, supportive care, intubation as
necessary
TICK PARALYSIS
3 month old F w/ decreased activity, poor feeding,
constipation
Weak cry, decreased wet diapers
Previously healthy, vaccines up-to-date
CASE 6
BP 98/64, P 114, T 37.0C, weight 5.3 kg (75th %), height 57
cm (50%)
Awake, no distress, weak cry
Poor head control
Decreased pupillary reflexes, absent corneal reflexes,
bilateral ptosis
CASE 6
Weak suck and gag reflexes, increased oral secretions
Abd soft, non-tender, no HSM, decreased bowel sounds
throughout
Decreased muscle tone, decreased DTRs throughout
No rashes or petechiae
CASE 6
C. botulinum: anaerobic spore-forming bacterium
Types A, B, E, F cause human disease
Preformed toxin irreversible inhibition of ACh release at NMJ
Descending, symmetric, flaccid paralysis 6-48 hrs post-
ingestion
BOTULISM
CN and bulbar muscles affected first
Anticholinergic Sx
Pupils dilated, unresponsive to light (differentiates from
myasthenia gravis)
Normal or diminished DTRs
BOTULISM
Infants especially susceptible (higher gut pH)
Spores survive in honey
Lethargy, poor feeding, weak cry, constipation
Diagnosis: clinical, stool/serum assay (usually send-out)
INFANTILE BOTULISM
Treatment: human botulinum immune globulin (BabyBIG),
intubate as necessary
Single dose reduces average hospital length from 5.5 wks to
2.5 wks and decreases intubation rate by 2/3
INFANTILE BOTULISM